Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The organic matrix of dentin and bone is a complex structural framework predominantly composed of Type I collagen (approximately 90%) and various non-collagenous proteins such as dentin sialophosphoprotein (DSPP) and osteocalcin (StatPearls, 2023). This matrix serves as the essential template for the deposition of hydroxyapatite crystals, providing hard tissues with their characteristic tensile strength and fracture resistance (PubMed, PMID: 22622760). In clinical dentistry, the preservation of this matrix is critical for the longevity of resin-dentin bonds, as degradation by endogenous enzymes like matrix metalloproteinases (MMPs) can lead to restoration failure (PubMed, PMID: 21247661). In bone, the matrix undergoes constant remodeling by osteoblasts and osteoclasts, a process targeted by pharmacological agents to treat metabolic bone diseases (NIH, 2022). Therapeutic strategies often focus on stabilizing the collagen network through cross-linking agents or preventing its breakdown to maintain structural integrity (PubMed, PMID: 25603115). Furthermore, the interaction between the organic matrix and the mineral phase is a dynamic process that influences the overall bio-mechanical properties of the skeletal and dental systems (PubChem, 2024).
Stabilization of the collagenous framework through chemical cross-linking or the inhibition of endogenous proteolytic enzymes (MMPs and cathepsins) to prevent matrix degradation and maintain structural integrity.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Collagen and organic matrix in dentin and bone.